Krystal Biotech, Inc. (K1YS34)
Market Closed
26 Mar, 07:55 PM
B3 B3 Primary R$
44. 80
0
0%
R$
1.33B Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
R$ 44.8
Previous Close Want to track K1YS34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Krystal Biotech, Inc. (K1YS34) Statistics
Valuation metrics
Market Cap 1.33B
Enterprise value 2.51B
Trailing P/E (ttm) 1.16
Forward P/E -
PEG ratio 0.03
Price/Sales (ttm) 3.01
Price/Book (mrq) 0.19
Enterprise Value/Revenue 1.11
Enterprise Value/EBITDA 2.46
Overview
Shares outstanding 29.6M
Float 23.62M
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 44.8
52-Week high 44.8
Beta 0.54
50-Day moving average 44.8
200-Day moving average 44.8
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 30 Jun 2026
Profitability
Profit margin 0.55%
Operating margin 0.49%
Operational effectiveness
Return on assets 0.09%
Return on equity 0.2%
Income Statement
Revenue (ttm) 2.26B
Revenue per share (ttm) 15.08
Quarterly revenue growth (yoy) 0.24%
Gross profit (ttm) 2.14B
EBITDA 204.42M
Net income to common (ttm) 1.24B
Diluted EPS (ttm) 38.54
Quarterly earnings growth (yoy) 0.43%
Balance Sheet
Total cash (mrq) 4.34B
Total cash per share (mrq) 28.57
Total debt (mrq) 45.4M
Total Debt/Equity (mrq) 0.65
Current ratio (mrq) 8.32%
Book value per share (mrq) 238.53
Cash Flow
Cash flow statement 1.4B
Levered free cash flow (LFCF) 778.08M
2026 © Marketlog. All Rights Reserved.
